Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs VanEck Semiconductor ETF (SMH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs VanEck Semiconductor ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B), while VanEck Semiconductor ETF trades at $603.33 (market cap $73.92B). The key difference: VanEck Semiconductor ETF is far larger — about 32.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and VanEck Semiconductor ETF is more actively traded (11,050,892 versus 4,179,659). Which is the better fit depends on your goals.
| SLS | SMH | |
|---|---|---|
Market Cap | $2.27B | $73.92B |
Volume | 4,179,659 | 11,050,892 |
Sector | Health | — |
52-Week High | $15.46 | $668.91 |
52-Week Low | $1.39 | $325.10 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 101 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SMH trades at $603.33, down 3.47% on the day, but maintains a bullish technical outlook with strong moving average support. The semiconductor ETF has delivered exceptional returns, up approximately 69% year-to-date through September 30, 2026, significantly outperforming the broader market. Recent sector strength is driven by AI demand and positive industry developments, including AMD's $8.2 billion acquisition of World Labs.
The semiconductor sector's structural growth, particularly in AI applications, supports continued upside potential. However, concentration risk in top holdings like Nvidia and sensitivity to US-China trade tensions present meaningful headwinds. Current technical levels suggest support at $597 with resistance at $620, providing clear near-term trading parameters.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About VanEck Semiconductor ETF
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →
